Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bebird is a consumer health and device company focused on smart visual ear care products for home use. The company markets app-connected otoscope and ear-cleaning devices that combine imaging, inspection, and wax-removal functions, and it also promotes broader ear, nose, and throat observation tools. Bebird appears to operate primarily as a commercial-stage device brand rather than a therapeutics developer, with products sold globally through its own online store and distribution channels. Public-facing materials describe the business as combining R&D, manufacturing, and sales, with roots in Shenzhen and a U.S. operating entity for distribution. For a biotech analyst, the key point is that Bebird is healthcare-adjacent and device-oriented, not a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bebird.